Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2024

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Key Northeast Hub with Addition of New England Area Dealer

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced the addition of zero-emissions commercial vehicle dealership, Eco Auto, a Boston, Massachusetts-area dedicated EV dealer. As Mullen’s newest franchise dealer, Eco Auto will cover national fleet opportunities for the … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Mullen Automotive Inc. (NASDAQ: MULN) Class 3 EV Truck Receives CARB Certification, Joins Class 1 EV Van in Meeting Stringent Emission Standards

With environmental concerns becoming an increasing priority, more states, companies, and consumers are paying attention to — and prioritizing — environmentally friendly products and practices. Mullen Automotive (NASDAQ: MULN), an emerging EV manufacturer, shares this commitment to being environmentally responsible. To underscore this … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’

Recent Achievements Investment Considerations Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”). Annovis Bio stands out by developing a drug that targets multiple … Continue reading

Posted in Annovis Bio Inc. ANVS | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company announced today that on June 5, 2024, it received a formal … Continue reading

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Poised to Help NYC Deal with Rat Menace

SenesTech (NASDAQ: SNES) is a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats. The company has been rapidly growing with its unique solutions, defined by its two main offerings – … Continue reading

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Leveraging Unique Strategy Amid Transition to Renewables

Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. CIPI is helping to promote the adoption of renewable energy at a corporate level for mid-tier companies that are often overlooked by … Continue reading

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

SenesTech Inc. (NASDAQ: SNES) Set to Revolutionize Rodent Pest Control for Everyday Consumers Following Amazon Store Launch

SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its dedicated online store on Amazon. As the world’s largest online retailer, this … Continue reading

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Raises ~$2.7M in Warrant Inducement Offering

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, recently closed on a warrant inducement offering. The company received gross proceeds of $2,786,174 from the transaction. Aegis Capital Corp. acted as the exclusive placement agent for … Continue reading

Posted in SOBRsafe Inc. SOBR | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Patent Portfolio to 43 Granted Patents Worldwide

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, started 2024 with a portfolio of 38 patents granted worldwide, having received ten new granted patents during 2023, the most yet in a single year. That patent portfolio, company … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment